EMAP II, human recombinant | 4463

Endothelial-Monocyte Activating Polypeptide-II (EMAP-II) is a tumor derived cytokine that is an anti-angiogenic factor in tumor Vascular development, and strongly inhibits tumor growth. Recombinant human EMAP-II is an 18.3 kDa protein containing 166 amino acid residues.

4463 | EMAP II human recombinant DataSheet

Biomolecule/Target: EMAP II

Synonyms: AIMP1, EMAP2, EMAP-2, EMAPII, SCYE1, Multisynthetase complex auxiliary component p43, Endothelial monocyte-activating polypeptide 2, EMAP-II, p43,

Alternates names: IFN- 1, Interferon -

Taglines: A proinflammatory cytokine chemotactic for monocytes and granulocytes

NCBI Gene ID #: 3439

NCBI Gene Symbol: IFNA1

Gene Source: Human

Accession #: NM_024013

Recombinant: Yes

Source: E. coli

Purity by SDS-PAGEs: 95%

Assay: SDS-PAGE

Purity: N/A

Assay #2: HPLC

Endotoxin Level: <0.1 ng/g

Activity (Specifications/test method): N/A

Biological activity: N/A

Results: 20-40 ng/ml

Binding Capacity: N/A

Unit Definition: N/A

Molecular Weight: 19.3 kDa

Concentration: N/A

Appearance: Lyophilized protein

Physical form description: Lyophilized from a concentrated (1 mg/ml) solution in HO containing 20 mM sodium Phosphate buffer pH7.5 and 130 mM sodium chloride.

Reconstitution Instructions: Reconstitute in HO to a concentration of 0.1-1 mg/ml. This solution can then be diluted into other aqueous buffers

Amino acid sequence: N/A